tiprankstipranks
Lumos Pharma reports Q3 net loss $7.5M
PremiumThe FlyLumos Pharma reports Q3 net loss $7.5M
1M ago
Lumos Pharma enters merger agreement with Double Point Ventures to go private
Premium
The Fly
Lumos Pharma enters merger agreement with Double Point Ventures to go private
1M ago
Lumos Pharma initiated with a Buy at EF Hutton
Premium
The Fly
Lumos Pharma initiated with a Buy at EF Hutton
2M ago
Lumos Pharma reports Q1 EPS ($1.29), consensus ($1.18)
PremiumThe FlyLumos Pharma reports Q1 EPS ($1.29), consensus ($1.18)
6M ago
Is LUMO a Buy, Before Earnings?
Premium
Pre-Earnings
Is LUMO a Buy, Before Earnings?
7M ago
Lumos Pharma receives notice of allowance from USPTO for LUM-201 patent
Premium
The Fly
Lumos Pharma receives notice of allowance from USPTO for LUM-201 patent
8M ago
Lumos Pharma reports Q3 EPS ($1.04), consensus ($1.15)
PremiumThe FlyLumos Pharma reports Q3 EPS ($1.04), consensus ($1.15)
1y ago
Lumos Pharma announces new data, analysis of patient from OraGrowtH212 trial
Premium
The Fly
Lumos Pharma announces new data, analysis of patient from OraGrowtH212 trial
1y ago
Lumos Pharma price target lowered to $10 from $14 at Cantor Fitzgerald
Premium
The Fly
Lumos Pharma price target lowered to $10 from $14 at Cantor Fitzgerald
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100